Immune checkpoint inhibitors in ocular melanomas: contrasting efficacy with cutaneous melanomas

Immunotherapy. 2020 Nov;12(16):1149-1152. doi: 10.2217/imt-2020-0234. Epub 2020 Oct 20.

Authors

Sandra Hoyek¹, Hampig Raphael Kourie², Chris Labaki³, Joelle Antoun¹

Affiliations

¹ Ophtalmology Department, Faculty of Medicine, Saint Joseph University of Beirut, Lebanon.
² Hematology-Oncology Department, Faculty of Medicine, Saint Joseph University of Beirut, Lebanon.
³ Faculty of Medicine, Saint Joseph University of Beirut, Lebanon.

PMID: 33076742
DOI: 10.2217/imt-2020-0234

No abstract available

Keywords: cutaneous melanoma; immune checkpoint inhibitors; immunotherapy; ocular melanoma; uveal melanoma.

Publication types

Editorial

MeSH terms

Eye Neoplasms / immunology
Eye Neoplasms / therapy*
Humans
Immune Checkpoint Inhibitors / therapeutic use*
Melanoma / immunology
Melanoma / therapy*
Skin Neoplasms / immunology
Skin Neoplasms / therapy*
Treatment Outcome

Substances

Immune Checkpoint Inhibitors